Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique
- PMID: 8668675
- DOI: 10.1023/a:1016064930502
Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique
Abstract
Purpose: The purpose of this study was to develop a new method to produce albumin particles in the sub-200-nanometer range with a narrow size distribution and in a controlled and reproducible manner.
Methods: A new emulsion crosslinking method was developed using ultrasound and static mixing as homogenization steps and a central composite design was used to evaluate the influence of different process parameters on particle size, polydispersity and yield.
Results: Response surface analysis allowed the location of the most important factors. Of all the factors investigated, only the albumin concentration and the aqueous phase volume showed a significant influence on response parameters. Albumin nanospheres with sizes below 200 nm in diameter and very narrow size distributions were obtained in high yields ( > 80%).
Conclusions: This study describes a new preparation method for albumin nanoparticles which are suitable for future drug targeting studies.
Similar articles
-
Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.J Control Release. 2005 Aug 18;106(1-2):62-75. doi: 10.1016/j.jconrel.2005.04.005. J Control Release. 2005. PMID: 15922472
-
Immobilization of active urokinase on albumin microspheres: use of a chemical dehydrant and process monitoring.Pharm Res. 1992 Jun;9(6):776-81. doi: 10.1023/a:1015855622459. Pharm Res. 1992. PMID: 1409360
-
Enhanced oral bioavailability of calcium using bovine serum albumin microspheres.Drug Deliv. 2012 Aug;19(6):277-85. doi: 10.3109/10717544.2012.704094. Epub 2012 Aug 28. Drug Deliv. 2012. PMID: 22928732
-
Synthesis of BSA/Fe3O4 magnetic composite microspheres for adsorption of antibiotics.Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):4401-8. doi: 10.1016/j.msec.2013.06.038. Epub 2013 Jul 1. Mater Sci Eng C Mater Biol Appl. 2013. PMID: 23910359
-
Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.Int J Pharm. 2007 Mar 21;333(1-2):103-11. doi: 10.1016/j.ijpharm.2006.10.005. Epub 2006 Oct 7. Int J Pharm. 2007. PMID: 17079101
Cited by
-
Redox-sensitive cross-linking enhances albumin nanoparticle function as delivery system for photodynamic cancer therapy.J Nanomed Nanotechnol. 2016 Jun;6(3):294. doi: 10.4172/2157-7439.1000294. Epub 2015 May 22. J Nanomed Nanotechnol. 2016. PMID: 27088048 Free PMC article.
-
Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating.Pharm Res. 2008 Dec;25(12):2896-909. doi: 10.1007/s11095-008-9692-2. Epub 2008 Aug 15. Pharm Res. 2008. PMID: 18709447
-
Study of the combined treatment of lung cancer using gene-loaded immunomagnetic albumin nanospheres in vitro and in vivo.Int J Nanomedicine. 2016 Mar 15;11:1039-50. doi: 10.2147/IJN.S98519. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27042059 Free PMC article.
-
Adaptive neuro-fuzzy modeling of poorly soluble drug formulations.Pharm Res. 2006 Jun;23(6):1157-64. doi: 10.1007/s11095-006-0021-3. Epub 2006 May 25. Pharm Res. 2006. PMID: 16715373
-
Synthesis and Comparative Study of Nanoparticles Derived from Bovine and Human Serum Albumins.Polymers (Basel). 2020 Jun 6;12(6):1301. doi: 10.3390/polym12061301. Polymers (Basel). 2020. PMID: 32517219 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources